Noreen Kamal | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Christian Messina | Neuromuscular Diseases | Best Researcher Award

Published on by Neuroscientists

Dr. Christian Messina | Neuromuscular Diseases | Best Researcher Award

Dr. Christian Messina, Azienda Sanitaria Provinciale Caltanissetta, Italy.

Dr. Christian Messina is an accomplished Italian neurologist with a strong academic foundation and a growing impact in the fields of neuromuscular diseases, demyelinating disorders, and dementia. He holds multiple advanced degrees and certifications in neurology and neurophysiology and is currently pursuing further specialization. Practicing across Sicily, he brings clinical expertise to both urban and regional settings. His research contributions, notably the identification of a novel hATTR variant and the use of eculizumab in myasthenic crisis, underscore his innovative approach to complex neurological conditions. With 12 high-impact publications and memberships in major neurological societies, Dr. Messina is a rising voice in Italian and international neuroscience.

Profile

orcid

Early Academic Pursuits

Dr. Christian Messina’s journey into the realm of neuroscience began with distinction at the University of Catania, where he completed his specialization in Neurology with honors. From the outset, his academic excellence set the tone for a career marked by precision, curiosity, and deep commitment to the neurological sciences. Driven by a passion for continuous learning, he later earned a Master’s degree in Adult and Geriatric Neuropsychology from the University of Chieti, and he is currently advancing his expertise through a second Master’s in Neurophysiology at the University of Milan.

Professional Endeavors in Neurology

Currently serving as a Dirigente Medico di I Livello at the Azienda Sanitaria Provinciale in Caltanissetta, Italy, Dr. Messina actively practices across multiple Sicilian provinces including Catania, Messina, Enna, and Siracusa. He undertook a six-month fellowship in neuromuscular disorders at the esteemed Neuromuscular Disease Center, University of Palermo, which sharpened his clinical acumen in diagnosing and managing complex neurological disorders. His work is deeply integrated into regional neurological care and remains pivotal in advancing both adult and pediatric neurophysiological diagnostics.

Contributions and Research Focus

Dr. Messina’s research is primarily focused on neuromuscular diseases, demyelinating CNS disorders such as multiple sclerosis, and dementia-related conditions. He has made significant contributions by identifying and clinically characterizing a novel hereditary transthyretin amyloidosis (hATTR) variant, and has proposed innovative therapies such as eculizumab in myasthenic crises. His work has also enhanced understanding of seronegative myasthenia gravis, adding valuable insight to the field. In his clinical publications, he often sheds light on rare genotypic and phenotypic presentations, offering clarity in diagnostic and therapeutic approaches.

Accolades and Recognition

With 12 peer-reviewed publications in high-impact SCI and Scopus-indexed journals, Dr. Messina has built a respected profile in academic neurology. His citation index—H-index 3 on Google Scholar, and 2 on Scopus and Web of Science—reflects the growing relevance of his scholarly contributions. He is also an active member of Italy’s foremost neurological societies including SIN, SINC, and LICE, through which he remains engaged in cutting-edge developments and collaborative scientific exchange.

Impact and Influence

Through his research on biological therapies in myasthenia gravis and the development of normative neurophysiological values for peripheral sensory nerve conduction, Dr. Messina has begun to influence how age-specific neurodiagnostic standards are developed globally. His clinical insights and research have the potential to improve diagnostic accuracy and treatment responses for patients across varying age groups. Furthermore, his documented work on rare variants not only expands medical literature but also enables precision medicine in neurology.

Innovation and Vision

Dr. Messina embodies a spirit of clinical innovation, demonstrated by his proactive application of novel therapeutics and diagnostic strategies. His current research continues to explore predictive markers for treatment response, bridging the gap between laboratory science and patient care. His vision is rooted in translating neurophysiological evidence into accessible, everyday clinical protocols that can be adopted widely in both primary and tertiary care settings.

Legacy and Future Contributions

Poised to become a thought leader in clinical neuroscience, Dr. Christian Messina’s dedication to rigorous research and compassionate practice is setting the foundation for a career of enduring impact. As he progresses toward completing his second master’s and expands his portfolio of publications, his work promises to shape the future of neurodiagnostics and neuromuscular care. His commitment to both the academic and clinical communities ensures that his contributions will continue to benefit patients, professionals, and scholars for years to come.

Publication

1. Double seronegative myasthenia gravis and mimics: a retrospective cross-sectional study by two tertiary centers in the Southern Italy
Authors: Maccora S., Vinciguerra C., Messina C., Bevilacqua L., Rini N., Barone P., Brighina F., Di Stefano V.
Year: 2025

2. Woodhouse-Sakati syndrome: A review
Author: Messina C.
Year: 2025

3. Prominent and fast response to eculizumab in myasthenic crisis: the potential as rescue therapy in refractory myasthenia gravis
Authors: Messina C., Basile L., Crescimanno G., Battaglia S., Scichilone N., Brighina F., Di Stefano V.
Year: 2025

4. Stroke Warning Syndrome as the Initial Manifestation of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy
Author: Messina C.
Year: 2025

5. Expanding the Genetic and Phenotypic Spectrum of Kearns-Sayre Syndrome: A Case Report
Author: Messina C.
Year: 2025

6. Woman with Breast Cancer Presenting with Opsoclonus–Myoclonus Syndrome: A Case Report and Literature Review
Authors: Cipolla C., Gebbia V., Di Stefano V., Messina C., Sambataro D., Brighina F., Mesi C., Greco M., Cortegiani A., Valerio M.R.
Year: 2025

7. Genetic Screening for Hereditary Transthyretin Amyloidosis in the Population of Cammarata and San Giovanni Gemini Through Red Flags and Registry Archives
Authors: Di Stefano V., Messina C., Pignolo A., Pecoraro F., Cutrò I., Alonge P., Rini N., Quartetti U., Lo Bue V., Borgione E., et al.
Year: 2025

8. A New Form of Combined Hyperactive Dysfunction Syndrome: A Unique Case
Author: Messina C.
Year: 2025

9. Expanding the Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis: The Glu61Ala Variant
Authors: Messina C., Gulizia S., Scalia F., Borgione E., Cappello F., Brighina F., Di Stefano V.
Year: 2025

10. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
Authors: Zanghì A., Avolio C., Signoriello E., Abbadessa G., Cellerino M., Ferraro D., Messina C., Barone S., Callari G., Tsantes E., et al.
Year: 2022

Conclusion

Dr. Messina represents a dynamic blend of clinical excellence and research innovation. His work has already made meaningful contributions to the understanding of rare neuromuscular conditions and therapeutic strategies. As he continues to pursue advanced training and lead impactful research, his influence in the field is expected to grow. He is a strong candidate for prestigious recognitions such as the Best Researcher Award or Excellence in Innovation Award, with the promise of making sustained contributions to neuroscience, clinical neurophysiology, and patient-centered neurological care in the years ahead.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Kambiz Akbari Noghabi | Biological Sciences | Best Researcher Award

Prof. Dr. Kambiz Akbari Noghabi, National Institute of Genetic Engineering and Biotechnology (NIGEB), Iran.

Dr. Kambiz Akbari Noghabi is a distinguished microbiologist and biotechnologist whose academic journey began with a Ph.D. in Applied Microbiology-Biotechnology from Gyeongsang National University, South Korea. His pioneering research on cold-induced biopolymers by Pseudomonas fluorescens has been a cornerstone in microbial environmental applications. With a strong foundation in environmental and industrial biotechnology, his research explores the molecular biology of microorganisms, focusing on their potential to address pressing ecological issues.

Profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Kambiz Akbari Noghabi embarked on his academic journey with a deep passion for the microscopic world of microorganisms. He pursued his Ph.D. in Applied Microbiology-Biotechnology at Gyeongsang National University (GNSU), South Korea, from 2003 to 2006. Demonstrating academic excellence, he graduated with an average grade of “A.” His doctoral thesis, entitled “Production of a novel cold-induced biopolymer by Pseudomonas fluorescens BM07; its structural characterization & environmental applications,” not only explored an innovative microbial product but also reflected his dedication to eco-conscious scientific discovery. Recognizing his outstanding capabilities, he was awarded a prestigious BK21 (Brain Korea 21 Program) scholarship—one of South Korea’s most competitive supports for international scholars.

🧫 Research Focus and Scientific Curiosity

Driven by a profound interest in microbial science, Dr. Akbari Noghabi’s research is centered on Environmental and Industrial Biotechnology, with an emphasis on the cellular and molecular biology of microorganisms. His interdisciplinary work spans microbial natural products, environmental microbiology, and bio-nanotechnology. He has continuously explored innovative applications of microbes in solving environmental challenges, demonstrating an exceptional blend of academic rigor and creativity. His research on cold-induced biopolymers remains an example of how basic microbiological insight can inspire sustainable technological advancement.

🔬 Professional Endeavors and Multidisciplinary Integration

Throughout his career, Dr. Akbari Noghabi has collaborated across various disciplines within biological sciences. His scientific curiosity led him to initiate and participate in multidisciplinary projects, which often integrate aspects of biotechnology, molecular biology, and environmental engineering. Whether exploring the behavior of bacteria at the genetic level or developing new methods for environmental cleanup using microbial technologies, he has consistently contributed to the expanding interface between science and society.

🏅 Accolades and Recognition

Recognition has been a natural outcome of Dr. Akbari Noghabi’s relentless pursuit of scientific excellence. His academic merit earned him the highly respected BK21 scholarship during his doctoral studies, acknowledging him as an emerging leader in biotechnology. Beyond this, his work continues to be acknowledged globally through invitations to contribute as a referee for some of the most prestigious scientific journals, affirming the value and credibility of his scientific judgment.

📚 Refereeing Excellence and Scholarly Impact

As a reviewer for an extensive list of world-renowned journals—including Enzyme and Microbial Technology, Bioresource Technology, Scientific Reports, PLoS ONE, and Biotechnology & Bioengineering—Dr. Akbari Noghabi has helped shape the direction of microbial biotechnology research. His engagement with journals from Elsevier, Wiley, Springer, and others reflects not only his subject expertise but also the trust placed in him by the global scientific community to uphold rigorous academic standards and promote impactful research.

🌍 Impact on Science and Society

Dr. Akbari Noghabi’s work carries significant implications for both science and society. His research contributes directly to solving real-world problems, especially in the realm of environmental sustainability. By leveraging microbial capabilities for biopolymer production and environmental remediation, he has provided pathways for cleaner technologies and greener industry practices. His contributions echo in environmental policy discussions, technological innovation, and the academic development of future scientists.

🔮 Legacy and Future Contributions

Looking forward, Dr. Kambiz Akbari Noghabi remains poised to inspire the next generation of biotechnologists and microbiologists. His career is a testament to the power of interdisciplinary science, international collaboration, and persistent curiosity. With a legacy already grounded in scientific integrity and environmental advocacy, his ongoing efforts will undoubtedly continue to shape the future of microbial biotechnology and its applications across sectors.

Publication

  • Title: An efficient biosurfactant-producing bacterium Pseudomonas aeruginosa MR01, isolated from oil excavation areas in south of Iran
    Authors: TB Lotfabad, M Shourian, R Roostaazad, AR Najafabadi, MR Adelzadeh, …
    Year: 2009

 

  • Title: Biosurfactant-producing bacterium, Pseudomonas aeruginosa MA01 isolated from spoiled apples: physicochemical and structural characteristics of isolated biosurfactant
    Authors: H Abbasi, MM Hamedi, TB Lotfabad, HS Zahiri, H Sharafi, F Masoomi, …
    Year: 2012

 

  • Title: Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals
    Authors: F Shahcheraghi, M Abbasalipour, MM Feizabadi, GH Ebrahimipour, …
    Year: 2011

 

  • Title: Structural characterization of a rhamnolipid-type biosurfactant produced by Pseudomonas aeruginosa MR01: enhancement of di-rhamnolipid proportion using gamma irradiation
    Authors: TB Lotfabad, H Abassi, R Ahmadkhaniha, R Roostaazad, F Masoomi, …
    Year: 2010

 

  • Title: Efficient phenol degradation by a newly characterized Pseudomonas sp. SA01 isolated from pharmaceutical wastewaters
    Authors: M Shourian, KA Noghabi, HS Zahiri, T Bagheri, R Karbalaei, M Mollaei, …
    Year: 2009

 

  • Title: Characterization of a chitinase with antifungal activity from a native Serratia marcescens B4A
    Authors: M Zarei, S Aminzadeh, H Zolgharnein, A Safahieh, M Daliri, KA Noghabi, …
    Year: 2011

 

  • Title: A bio-inspired strategy for the synthesis of zinc oxide nanoparticles (ZnO NPs) using the cell extract of cyanobacterium Nostoc sp. EA03: from biological function to toxicity
    Authors: M Ebadi, MR Zolfaghari, SS Aghaei, M Zargar, M Shafiei, HS Zahiri, …
    Year: 2019

 

  • Title: Halophiles and their vast potential in biofuel production
    Authors: MA Amoozegar, A Safarpour, KA Noghabi, T Bakhtiary, A Ventosa
    Year: 2019

 

✅ Conclusion

Dr. Kambiz Akbari Noghabi’s work stands at the intersection of innovation, environmental responsibility, and scientific excellence. Through his research and professional service, he has carved out a lasting legacy in microbial biotechnology. His commitment to advancing the frontiers of science while addressing environmental challenges ensures that his contributions will continue to resonate across generations of researchers and practitioners. Looking ahead, his career promises even greater strides in the pursuit of sustainable, microbe-driven solutions to global problems.

Paolo Grumati | Cell Biology | Best Researcher Award

Published on by Neuroscientists

Prof. Paolo Grumati | Cell Biology | Best Researcher Award

Prof. Paolo Grumati,  TIGEM, Italy.

Dr. Paolo Grumati is a prominent researcher and academic with a focus on molecular biology, particularly the study of autophagy and its role in diseases such as muscular dystrophies and neurodegenerative disorders. His academic journey, beginning with a Master’s and Ph.D. from the University of Padova, laid the foundation for his pioneering work in the molecular mechanisms underlying disease pathogenesis. Dr. Grumati’s professional endeavors have included roles at esteemed institutions like Johann Wolfgang Goethe University and the Telethon Institute of Genetics and Medicine (TIGEM), where he leads groundbreaking research in selective autophagy. His work, which integrates advanced techniques like CRISPR/Cas9, has earned him widespread recognition and numerous accolades, including positions as Associate Professor at the University of Naples. His research has had a significant impact on the scientific community, particularly in the areas of cellular maintenance and therapeutic development.

Profile

Scopus

 

Early Academic Pursuits 🎓


Paolo Grumati’s academic journey began at the University of Padova in Italy, where he pursued a Master’s Degree in Medical Biotechnologies, graduating in 2005. His deep curiosity in the molecular underpinnings of human biology led him to continue his studies with a Ph.D. in Genetic and Molecular Biology, completed between 2006 and 2009. During his Ph.D., he focused on the genetic mechanisms that contribute to various diseases, a pursuit that sparked his lasting interest in molecular biology and disease pathogenesis. His early academic training laid a strong foundation for his future research in the biochemistry of diseases, especially those that affect muscle function and cellular processes.

Professional Endeavors 💼


Dr. Grumati’s professional career has been marked by an impressive trajectory across prestigious institutions. After completing his postdoctoral work on the pathogenesis of muscular dystrophies at the University of Padova, he moved to Germany, where he took a position at the Institute of Biochemistry II at Johann Wolfgang Goethe University. There, between 2013 and 2018, he specialized in the biochemistry and molecular biology of autophagy, a crucial cellular process related to health and disease. His expertise in autophagy became a defining element of his career, and in 2019, he was appointed as the Assistant Investigator and Head of the Mass Spectrometry Core at the Telethon Institute of Genetics and Medicine (TIGEM), where he leads innovative research into the molecular mechanisms of selective autophagy. Throughout these roles, Dr. Grumati has built a reputation for integrating advanced techniques like CRISPR/Cas9 into his work, influencing the field of genetic research.

Contributions and Research Focus 🔬


Dr. Grumati’s research focus has consistently revolved around the intricate molecular processes that govern cellular maintenance and disease, particularly through the lens of autophagy. Since becoming a principal investigator in 2019, his work at TIGEM has concentrated on understanding the molecular mechanisms of selective autophagy, which plays a pivotal role in cellular health and disease. He has pioneered methods to study and manipulate these processes, contributing significantly to the understanding of diseases such as muscular dystrophies and neurodegenerative disorders. His research not only delves into the underlying biology of these conditions but also seeks to identify therapeutic targets that could help manage or even cure these diseases.

Accolades and Recognition 🏆


Dr. Grumati has received widespread recognition for his work in molecular biology and biochemistry. His contributions to the field of autophagy and muscle biology have been honored with leadership roles in prominent research teams, including his time as Team Leader of the Frankfurt CRISPR/Cas9 Screening Center. His excellence in research has earned him a faculty position as Assistant Professor at the University of Naples “Federico II” and an eventual promotion to Associate Professor in 2024. His expertise in mass spectrometry and molecular biology has also made him a sought-after figure in the scientific community, where he is frequently invited to collaborate on interdisciplinary research projects.

Impact and Influence 🌍


Dr. Grumati’s research has had a lasting impact on the scientific community, particularly in the fields of autophagy and muscular dystrophies. His work has influenced both theoretical and applied aspects of molecular biology, from basic research to potential therapeutic interventions. Through his leadership at TIGEM and his involvement in international collaborations, Dr. Grumati has helped to shape the direction of research into autophagy-related diseases. His studies have not only provided insights into the cellular mechanisms at play in these diseases but also paved the way for future therapeutic strategies. He is seen as a key figure in the advancement of precision medicine and molecular therapeutics.

Legacy and Future Contributions 🔮

As Dr. Grumati moves forward in his career, his contributions to the fields of genetics and molecular biology are expected to have a profound and lasting influence. His current work, focusing on selective autophagy, holds promise for the development of novel treatments for diseases that currently have limited therapeutic options. His legacy will likely include innovations in understanding cellular degradation processes and their application to genetic disorders and other diseases. The future of Dr. Grumati’s research will continue to explore the molecular intricacies of human health, offering the potential for breakthroughs in regenerative medicine and disease treatment.

Teaching and Mentorship 👨‍🏫


Beyond his research, Dr. Grumati has made a significant impact through his academic roles at the University of Naples. As an Associate Professor, he plays a key role in shaping the next generation of molecular biologists. His teaching focuses on imparting knowledge in genetics, biochemistry, and molecular biology, with an emphasis on practical research applications. His mentorship has helped guide many students and early-career researchers, who have gone on to make their own contributions to the field. Dr. Grumati’s ability to translate complex scientific concepts into accessible lessons ensures that his influence extends far beyond his own research.

Publication

  • Title: Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling
    Authors: M. de Risi, D. Cavezza, G. Torromino, P. Grumati, E. de Leonibus
    Year: 2025

 

  • Title: Two FAM134B isoforms differentially regulate ER dynamics during myogenesis
    Authors: V. Buonomo, K.O. Lohachova, A. Reggio, R.M. Bhaskara, P. Grumati
    Year: 2025

 

  • Title: Ezrin defines TSC complex activation at endosomal compartments through EGFR-AKT signaling
    Authors: G. Giamundo, D. Intartaglia, E. del Prete, R. De Cegli, I. Conte
    Year: 2025

 

  • Title: 3D Rotary Wet-Spinning (RoWS) Biofabrication Directly Affects Proteomic Signature and Myogenic Maturation in Muscle Pericyte–Derived Human Myo-Substitute
    Authors: A. Reggio, C. Fuoco, F. de Paolis, M. Costantini, C. Gargioli
    Year: 2025

 

  • Title: Cross-Linking Mass Spectrometry to Capture Protein Network Dynamics of Cell Membranome
    Authors: L. Santorelli, M. Costanzo, S. Petrosino, M. Ruoppolo, P. Grumati
    Year: 2025

 

  • Title: Mitochondrial mechanotransduction through MIEF1 coordinates the nuclear response to forces
    Authors: P. Romani, G. Benedetti, M. Cusan, G. Martello, S. Dupont
    Year: 2024

 

Conclusion


Dr. Paolo Grumati’s career exemplifies the integration of scientific inquiry with practical application, as his research continues to shed light on crucial molecular processes that affect human health. His contributions to the understanding of autophagy have opened new avenues for potential therapeutic strategies in treating genetic disorders and other diseases. As he continues to lead research at TIGEM and teach at the University of Naples, Dr. Grumati’s legacy is set to influence the fields of molecular biology, genetics, and medicine for years to come. His work remains pivotal in advancing both the theoretical understanding of disease mechanisms and the development of new therapeutic approaches, positioning him as a key figure in modern biomedical research.

Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Published on by Neuroscientists

Prof. Lin Jizhen | Cancer immunotherapy | Best Researcher Award

Prof.  Lin Jizhen, Union Hospital, Fujian Medical University, China.

Dr. Jizhen Lin is a distinguished physician-scientist whose career has been defined by an unwavering dedication to the field of auditory molecular biology. With his foundational medical education from Fujian Medical University and advanced research training in biochemistry and molecular biology at the University of Minnesota, he has seamlessly blended clinical acumen with scientific innovation. His professional roles have evolved from intern and research fellow to Associate Professor and Laboratory Director, reflecting a career rich in mentorship, discovery, and leadership. His research has focused extensively on otitis media and the molecular mechanisms of hearing, contributing valuable insights into the pathophysiology and potential treatments of auditory disorders.

Profile

Scopus

 

📚 Early Academic Pursuits

Dr. Jizhen Lin’s academic journey began with a strong foundation in medicine at Fujian Medical University, Fuzhou, China, where he earned his M.D. in 1982 and an M.S. in Otolaryngology in 1987. His thirst for advanced knowledge and scientific discovery later brought him to the University of Minnesota, Minneapolis, where he immersed himself in the fields of biochemistry and molecular biology, further enriching his expertise and setting the stage for a robust research career in auditory sciences.

🧪 Professional Endeavors

Dr. Lin’s professional path has been marked by consistent dedication and a progressive climb through academic and research positions. His early clinical exposure as an intern at Union Hospital in Fujian laid the groundwork for his subsequent transition into research. Between 1992 and 1995, he served as an International Research Fellow at the Otitis Media Research Center (OMRC), University of Minnesota. He continued to make strides as a Research Scientist and Co-director of the Otopathology-Molecular Biology Laboratory, contributing significantly to auditory molecular biology. His leadership abilities culminated in his appointment as Director of the Auditory Molecular Biology Laboratory, and he has been serving as an Associate Professor in the Department of Otolaryngology at the University of Minnesota Medical School since 2008.

🔬 Contributions and Research Focus

Throughout his career, Dr. Lin has concentrated on unraveling the complexities of auditory molecular biology with a primary focus on otitis media, a prevalent childhood disease. His contributions have been instrumental in bridging clinical otolaryngology with molecular science, employing biochemical tools to investigate the pathogenesis of auditory disorders. His laboratory has played a critical role in advancing understanding of the genetic and cellular mechanisms that underpin hearing loss and middle ear infections, particularly through innovative translational approaches.

🏅 Accolades and Recognition

Dr. Lin’s relentless pursuit of scientific excellence and impactful research has earned him widespread recognition in the field of otolaryngology. His tenure as a Graduate Faculty advisor reflects not only his dedication to mentorship but also the high regard his peers and the academic community have for his expertise. While he may not be adorned with numerous public awards, the esteem in which he is held by colleagues and students alike underscores the quiet yet profound impact of his scholarly work.

🌍 Impact and Influence

The influence of Dr. Lin’s research extends beyond the laboratory, as his findings have contributed meaningfully to clinical practices and therapeutic approaches in otolaryngology. By identifying key molecular targets and pathways involved in auditory disorders, his work continues to shape the development of novel diagnostics and treatments. Furthermore, his role in international research collaborations underscores his commitment to knowledge exchange and global scientific advancement.

🧠 Legacy and Future Contributions

Dr. Lin’s legacy is firmly rooted in the integration of molecular science with clinical otolaryngology, a field he has helped shape through decades of dedicated research and academic mentorship. As a mentor to future scientists and a contributor to critical advancements in auditory health, he remains a cornerstone in the bridge between basic science and patient care. Looking forward, his ongoing work in auditory molecular biology is poised to further uncover the mechanisms of hearing and hearing loss, promising new frontiers in medical intervention and auditory health.

🧬 Lifelong Commitment to Hearing Science

Dr. Lin’s career embodies a lifelong commitment to auditory science, from the clinic to the lab. His seamless blend of clinical knowledge, molecular expertise, and research leadership has fostered a rich legacy in otolaryngology. With ongoing contributions to scientific understanding and future discoveries on the horizon, Dr. Lin continues to inspire a generation of researchers and clinicians dedicated to improving hearing health worldwide.

Publication

  1. Title: Cell-free transcription amplification-based split-type electrochemical sensor using enzyme-linked magnetic microbeads for minimal residual leukemia detection
    Authors: Luying Yu, Jinyuan Chen, Huanjiao Weng, … Xinhua Lin, Guangxian Zhong
    Year: 2025

 

  1. Title: Antibody screening-assisted multichannel nanoplasmonic sensing chip based on SERS for viral screening and variants identification
    Authors: Yi Liu, Huanjiao Weng, Zhiwei Chen, … Shangyuan Feng, Duo Lin
    Year: 2025

 

  1. Title: tRNA methyltransferase DNMT2 promotes hepatocellular carcinoma progression and enhances Bortezomib resistance through inhibiting TNFSF10
    Authors: Junzhong Lai, Linqin Chen, Qiumei Li, … Jizhen Lin, Qi Chen
    Year: 2025

 

  1. Title: Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice
    Authors: Junzhong Lai, Jiadi Liang, Kunsen Chen, … Qi Chen, Jizhen Lin
    Year: 2024

 

  1. Title: B7H3 targeting gold nanocage pH-sensitive conjugates for precise and synergistic chemo-photothermal therapy against NSCLC
    Authors: Bing Chen, Kaifan Zheng, Shubin Fang, … Jizhen Lin, Xinhua Lin
    Year: 2023

 

  1. Title: A drug-delivery depot for epigenetic modulation and enhanced cancer immunotherapy
    Authors: Junzhong Lai, Jiadi Liang, Yong Zhang, … Jizhen Lin, Qi Chen
    Year: 2023

 

  1. Title: Ultrasensitive detection of SARS-CoV-2 antigen using surface-enhanced Raman spectroscopy-based lateral flow immunosensor
    Authors: Shuxia Lai, Yi Liu, Shubin Fang, … Jizhen Lin, Shangyuan Feng
    Year: 2023

 

  1. Title: Retraction Note to: Linc00210 drives Wnt/β-catenin signaling activation and liver tumor progression through CTNNBIP1-dependent manner
    Authors: Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, … Qinxian Zhang, Quanli Gao
    Year: Not specified

 

  1. Title: SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
    Authors: Libang Yang, Jiangbo Yang, Blake A. Jacobson, … Craig A. Henke, Jizhen Lin
    Year: 2022

 

✅ Conclusion

Dr. Lin’s lifelong commitment to understanding the science of hearing has positioned him as a pioneering figure in otolaryngology. Through decades of research, academic guidance, and clinical collaboration, he has built a legacy rooted in translational science and patient-centered innovation. His work continues to influence both basic research and clinical practice, promising a future where auditory health is better understood and more effectively managed. As a scientist, mentor, and innovator, Dr. Lin stands as an enduring contributor to the advancement of hearing science.

Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Published on by Neuroscientists

Prof. Jeffrey Holt | Hearing and Sensory Transduction | Lifetime achievement Award

Prof. Jeffrey Holt,  Harvard Medical School / Boston Children’s Hospital, United States.

Dr. Jeffrey R. Holt is a distinguished scientist whose groundbreaking contributions to auditory neuroscience and inner ear physiology have significantly advanced the field of otolaryngology. Currently serving as a Professor of Otolaryngology and Neurology at Boston Children’s Hospital and Harvard Medical School, Dr. Holt’s career is marked by an unwavering commitment to understanding the molecular and physiological mechanisms underlying hearing and balance disorders.

Profile

Google Scholar

 

Early Academic Pursuits 🎓

Born in Buffalo, NY, Dr. Holt’s passion for science was evident early in his academic journey. He earned his Bachelor of Science degree in Biology from Wofford College in 1986, laying a strong foundation in the life sciences. His quest for knowledge led him to the University of Rochester, where he pursued a Master’s degree in Physiology in 1992, followed by a Ph.D. in Physiology in 1995. His doctoral research provided deep insights into the intricate workings of sensory physiology, setting the stage for his future research endeavors in auditory neuroscience.

Professional Endeavors and Leadership 👩‍💼

Following his Ph.D., Dr. Holt embarked on postdoctoral training at Harvard Medical School, Massachusetts General Hospital, and the Howard Hughes Medical Institute. His extensive training in neurobiology enabled him to transition into academic roles, beginning as an Instructor in Neurobiology at Harvard Medical School and Massachusetts General Hospital from 1999 to 2001. He later joined the University of Virginia as an Assistant Professor of Neuroscience, where he progressed to Associate Professor before returning to Harvard in 2011. Since 2016, he has held the esteemed position of Professor of Otolaryngology at Boston Children’s Hospital and Harvard Medical School, as well as a faculty affiliation with the Harvard-MIT Health Sciences and Technology (HST) program.

Contributions and Research Focus 🌍

Dr. Holt’s pioneering research has been instrumental in decoding the molecular basis of hearing and balance disorders. His work focuses on sensory hair cells of the inner ear, aiming to uncover the genetic and physiological mechanisms that contribute to hearing loss. His studies have explored ion channel function, hair cell mechanotransduction, and gene therapy approaches for hereditary deafness. His innovative research has opened new avenues for therapeutic interventions, including the development of gene therapies targeting Usher syndrome and other genetic hearing disorders.

Accolades and Recognition 🏆

Throughout his career, Dr. Holt has been widely recognized for his contributions to auditory science. He has played key leadership roles in prestigious scientific organizations, serving as Chair of the Usher Syndrome Society Scientific Advisory Committee and Co-Chair of major international conferences such as the Keystone Conference on Sensory Systems and the New York Academy of Sciences Meeting. His service on various NIH and NIDCD advisory committees reflects his influence in shaping national research priorities in hearing and balance disorders.

Impact and Influence on Scientific Community 🌐

Dr. Holt’s impact extends beyond research, as he has been a dedicated mentor and educator throughout his career. He has guided numerous graduate students and postdoctoral fellows, serving on thesis and qualifying exam committees at Harvard Medical School. As a course director and research mentor, he has played a crucial role in training the next generation of auditory neuroscientists. His leadership in academic and scientific communities has helped bridge the gap between fundamental research and clinical applications in hearing restoration.

Legacy and Future Contributions 💪

With a legacy rooted in groundbreaking discoveries and scientific leadership, Dr. Holt continues to push the boundaries of auditory neuroscience. His ongoing research in gene therapy for hereditary deafness holds the promise of transforming lives through novel treatments for hearing loss. As a visionary in the field, his work is set to inspire future advancements in otolaryngology, offering hope to millions affected by hearing and balance disorders worldwide. His dedication to research, education, and clinical impact ensures that his contributions will leave a lasting imprint on auditory science for generations to come.

 

Publication

  • TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells
    Authors: DP Corey, J García-Añoveros, JR Holt, KY Kwan, SY Lin, MA Vollrath, …
    Year: 2004

 

  • Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
    Authors: X Gao, Y Tao, V Lamas, M Huang, WH Yeh, B Pan, YJ Hu, JH Hu, …
    Year: 2018

 

  • Mechanotransduction in mouse inner ear hair cells requires transmembrane channel–like genes
    Authors: Y Kawashima, GSG Géléoc, K Kurima, V Labay, A Lelli, Y Asai, …
    Year: 2011

 

  • TMC1 and TMC2 are components of the mechanotransduction channel in hair cells of the mammalian inner ear
    Authors: B Pan, GS Géléoc, Y Asai, GC Horwitz, K Kurima, K Ishikawa, …
    Year: 2013

 

  • Continuous evolution of base editors with expanded target compatibility and improved activity
    Authors: BW Thuronyi, LW Koblan, JM Levy, WH Yeh, C Zheng, GA Newby, …
    Year: 2019

 

  • Differential distribution of stem cells in the auditory and vestibular organs of the inner ear
    Authors: K Oshima, CM Grimm, CE Corrales, P Senn, R Martinez Monedero, …
    Year: 2007

 

  • A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells
    Authors: JR Holt, SKH Gillespie, DW Provance, K Shah, KM Shokat, DP Corey, …
    Year: 2002

 

  • A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear
    Authors: LD Landegger, B Pan, C Askew, SJ Wassmer, SD Gluck, A Galvin, …
    Year: 2017

 

  • Calcium imaging of single stereocilia in hair cells: localization of transduction channels at both ends of tip links
    Authors: W Denk, JR Holt, GMG Shepherd, DP Corey
    Year: 1995

 

  • TMC1 forms the pore of mechanosensory transduction channels in vertebrate inner ear hair cells
    Authors: B Pan, N Akyuz, XP Liu, Y Asai, C Nist-Lund, K Kurima, BH Derfler, …
    Year: 2018

 

Conclusion 🎯

Dr. Holt’s contributions to auditory neuroscience have revolutionized the field, bridging fundamental research with clinical applications. His groundbreaking work in gene therapy holds immense potential for treating hereditary hearing disorders, making a profound impact on global healthcare. As a researcher, educator, and leader, his legacy will continue to inspire innovation in otolaryngology and improve the lives of individuals affected by hearing and balance impairments for generations to come.

 

Vikash Kumar | Molecular Biology | Best Researcher Award

Published on by Neuroscientists

Dr. Vikash Kumar | Molecular Biology | Best Researcher Award

Dr. Vikash Kumar, Central Inland Fisheries Research Institute,  India.

Dr. Vikash Kumar is a distinguished scientist in the field of aquaculture and fish health management, with over 15 years of research experience. His academic journey, from earning a Ph.D. with distinction at Ghent University to holding key research positions at ICAR-CIFRI, has been marked by excellence. His expertise spans transcriptomics, proteomics, cellular biology, and immunohistochemistry, with a strong focus on understanding fish and shrimp immunological responses. His groundbreaking research on Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp and inflammation in Labeo rohita has significantly contributed to disease mitigation strategies in aquaculture. Recognized among the Top 2% of Scientists globally (Stanford/Elsevier, 2024), Dr. Kumar’s influence extends beyond research, shaping policies and fostering international collaboration.

profile

Google Scholar

 

🎓 Early Academic Pursuits

Dr. Vikash Kumar’s journey into the world of aquaculture and fish health began with a strong academic foundation. With a Bachelor of Fisheries Science from the College of Fisheries, India, he excelled in his studies, earning first-class distinction with an impressive 8.66/10.0 GPA. Building upon this, he pursued a Master of Fisheries Science in Fish Health from ICAR-Central Institute of Fisheries Education (CIFE), India, where he once again showcased academic brilliance, securing an 8.23/10.0 GPA. His thirst for knowledge and dedication to research led him to Belgium, where he earned his Ph.D. from the esteemed Laboratory of Aquaculture & Artemia Reference Center, Ghent University, in 2020. Awarded with distinction, his doctoral studies solidified his expertise in fish and shrimp immunology, setting the stage for a remarkable scientific career.

🏅 Professional Endeavors

With more than 15 years of experience in aquaculture and fish health management, Dr. Kumar has made significant strides in his field. His professional journey began in 2014 as a Scientist at the ICAR-Central Inland Fisheries Research Institute (ICAR-CIFRI) in Kolkata, India. After four years of dedicated service, he embarked on his doctoral research at Ghent University, where he explored critical aspects of aquatic immunology. Returning to ICAR-CIFRI in 2020 as a Senior Scientist, he continues to contribute to the advancement of fisheries research, working with diverse stakeholders and scientists to address pressing challenges in the aquaculture industry.

🔬 Contributions and Research Focus

Dr. Kumar’s research spans a broad spectrum of critical topics in aquaculture. His expertise in transcriptomics, proteomics, cellular biology, histology, immunohistochemistry, and electron microscopy has enabled him to unravel complex immunological responses in fish and shrimp. His work has provided invaluable insights into the virulence and pathogenesis of Acute Hepatopancreatic Necrosis Disease (AHPND) in shrimp, leading to the development of innovative mitigation strategies. Additionally, his research on carrageenan-induced inflammation in Labeo rohita has contributed to a deeper understanding of fish immune responses, paving the way for improved disease management in aquaculture.

🏆 Accolades and Recognition

Dr. Kumar’s contributions to fisheries science have earned him global recognition. He is ranked among the Top 2% of Scientists worldwide as per Stanford/Elsevier rankings in 2024, a testament to his impactful research and scientific excellence. His work is widely acknowledged in the scientific community, reflecting his dedication to enhancing the health and sustainability of aquatic species. His commitment to continuous learning and innovation has made him a respected figure in fisheries research, both in India and internationally.

🌍 Impact and Influence

Dr. Kumar’s research has significantly influenced disease management strategies in aquaculture, directly benefiting the fisheries industry. His work has helped improve diagnostic methods, develop novel treatment approaches, and enhance the overall resilience of aquaculture systems against infectious diseases. His ability to collaborate with researchers worldwide has fostered the exchange of knowledge, strengthening the global scientific network dedicated to sustainable aquaculture practices.

🔬 Legacy and Future Contributions

As a dedicated scientist, Dr. Kumar’s legacy is defined by his relentless pursuit of solutions for aquaculture challenges. His research continues to inspire young scientists, and his contributions are shaping the future of fish health management. Moving forward, he aims to expand his studies on disease mitigation strategies, explore cutting-edge biotechnological approaches, and contribute to policy frameworks that promote sustainable fisheries. His unwavering commitment to scientific advancement ensures that his impact will resonate for generations to come.Dr. Vikash Kumar stands as a beacon of excellence in aquaculture research, transforming the field with his expertise, passion, and vision for a healthier aquatic future.

publication

  • Genus Bacillus, Promising Probiotics in Aquaculture: Aquatic Animal Origin, Bio-Active Components, Bioremediation and Efficacy in Fish and Shellfish
    Authors: M Soltani, K Ghosh, SH Hoseinifar, V Kumar, AJ Lymbery, S Roy, E Ringø
    Year: 2019

 

  • Application of Probiotics in Shrimp Aquaculture: Importance, Mechanisms of Action, and Methods of Administration
    Authors: V Kumar, S Roy, DK Meena, UK Sarkar
    Year: 2016

 

  • Acute Hepatopancreatic Necrosis Disease (AHPND): Virulence, Pathogenesis and Mitigation Strategies in Shrimp Aquaculture
    Authors: V Kumar, S Roy, BK Behera, P Bossier, BK Das
    Year: 2021

 

  • Immunostimulants for Aquaculture Health Management
    Authors: D Barman, P Nen, SC Mandal, V Kumar
    Year: 2013

 

  • A Practical Approach on SDS PAGE for Separation of Protein
    Authors: S Roy, V Kumar
    Year: 2014

 

  • Phloroglucinol-Mediated Hsp70 Production in Crustaceans: Protection Against Vibrio Parahaemolyticus in Artemia Franciscana and Macrobrachium Rosenbergii
    Authors: V Kumar, K Baruah, DV Nguyen, G Smagghe, E Vossen, P Bossier
    Year: 2018

 

  • Biofloc Microbiome with Bioremediation and Health Benefits
    Authors: V Kumar, S Roy, BK Behera, BK Das
    Year: 2021

 

  • Acute Phase Proteins and Their Potential Role as an Indicator for Fish Health and in Diagnosis of Fish Diseases
    Authors: S Roy, V Kumar, V Kumar, BK Behera
    Year: 2017

 

Conclusion

Dr. Vikash Kumar’s contributions to aquaculture science are both profound and far-reaching. His work not only advances scientific understanding but also provides practical solutions for the sustainable growth of the fisheries industry. His dedication to innovation, research, and global collaboration cements his status as a leading scientist in his field. As he continues his pursuit of excellence, his impact on aquatic health management will undoubtedly shape the future of sustainable aquaculture and inspire upcoming generations of researchers. 🌊🐠

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.